Cosmos Health (STU:V67A) LT-Debt-to-Total-Asset : 0.05 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Cosmos Health LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Cosmos Health's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.05.

Cosmos Health's long-term debt to total assets ratio declined from Sep. 2023 (0.06) to Sep. 2024 (0.05). It may suggest that Cosmos Health is progressively becoming less dependent on debt to grow their business.

Cosmos Health LT-Debt-to-Total-Asset Historical Data

The historical data trend for Cosmos Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmos Health LT-Debt-to-Total-Asset Chart

Cosmos Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.02

0.28

0.27

0.06

Cosmos Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.06	0.06	0.05	0.05	0.05

Cosmos Health LT-Debt-to-Total-Asset Calculation

Cosmos Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	3.563	/	60.536
	=	0.06

Cosmos Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	2.811	/	58.133
	=	0.05

Cosmos Health (STU:V67A) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Cosmos Health LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Cosmos Health's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmos Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Cosmos Health Inc (STU:V67A) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

COSM:USA V67A:Germany

Address

5 Agiou Georgiou Street, Thessaloniki, Thessaloniki, GRC, 55438

Website

https://www.cosmoshealthinc.com

Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.

Cosmos Health Headlines

No Headlines